DGX:NYSE (USA) Also trade in: Germany

Quest Diagnostics Inc

$ 85.75 0.05 (0.06%)
On watch
Volume: 1,486,535 Avg Vol (1m): 1,278,564
Market Cap $: 11.54 Bil Enterprise Value $: 15.35 Bil
P/E (TTM): 16.21 P/B: 2.22
Earnings Power Value 39.16
Net Current Asset Value -32.57
Tangible Book -18.92
Projected FCF 76.98
Median P/S Value 73.14
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 5/10

Current vs industry vs history
Cash-to-Debt 0.04
Equity-to-Asset 0.47
Debt-to-Equity 0.75
Debt-to-EBITDA 2.77
Interest Coverage 6.54
Piotroski F-Score 5
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.18
DISTRESS
GREY
SAFE
Beneish M-Score -2.49
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 10.07%
WACC 6.98%

Profitability & Growth : 7/10

Current vs industry vs history
Operating Margin % 14.67
Net Margin % 9.77
ROE % 14.26
ROA % 6.82
ROC (Joel Greenblatt) % 76.20
3-Year Total Revenue Growth Rate 0.20
3-Year Total EBITDA Growth Rate -3.50
3-Year EPS w/o NRI Growth Rate 2.80

» DGX's 30-Y Financials

Financials (Next Earnings Date: 2019-04-23)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:DGX

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Diagnostics & Research » Diagnostics & Research    NAICS : 621511    SIC : 8071
Compare NAS:IDXX NYSE:LH XTER:SRT3 SZSE:300676 XPAR:BIM XSWX:LONN TSE:6869 XPAR:ERF NYSE:PKI NYSE:IQV NYSE:BIO NYSE:QGEN NAS:DXCM NYSE:A NAS:ICLR NAS:EXAS XTER:AFX NAS:PRAH MIL:DIA NYSE:CRL
Traded in other countries QDI.Germany
Address 500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates about 90% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing at its national network of 2,000 patient service centers. The firm also runs a diagnostic solutions segment which provides clinical trials testing, risk assessment services, and information technology solutions.

Ratios

Current vs industry vs history
PE Ratio (TTM) 16.21
Forward PE Ratio 13.32
N/A
PE Ratio without NRI 16.21
Price-to-Owner-Earnings 15.28
PB Ratio 2.22
PS Ratio 1.58
Price-to-Free-Cash-Flow 14.59
Price-to-Operating-Cash-Flow 9.93
EV-to-EBIT 14.02
EV-to-EBITDA 10.93
EV-to-Revenue 2.04
Shiller PE Ratio 18.25
Current Ratio 0.94
Quick Ratio 0.87
Days Inventory 7.02
Days Sales Outstanding 49.05
Days Payable 23.71

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 2.40
Dividend Payout Ratio 0.37
3-Year Dividend Growth Rate (Per Share) 9.90
Forward Dividend Yield % 2.47
N/A
Yield-on-Cost (5-Year) % 3.46
3-Year Share Buyback Rate 1.90

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 1.11
Price-to-Median-PS-Value 1.17
Earnings Yield (Joel Greenblatt) % 7.13
Forward Rate of Return (Yacktman) % 5.70

More Statistics

Revenue (TTM) (Mil) $ 7,531
EPS (TTM) $ 5.29
Beta 0.93
Volatility % 18.54
52-Week Range $ 78.95 - 116.49
Shares Outstanding (Mil) 134.58

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 5
Positive ROA Y
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy Y
Higher Gross Margin yoy N
Higher Asset Turnover yoy N